Propionic Acidemia

High protein intake or increased catabolism during illness triggers metabolic decompensation.

Infections commonly precipitate acute metabolic crises by increasing metabolic demands.

Fasting or poor feeding leads to increased endogenous protein breakdown and metabolite accumulation.

Administration of certain medications (e.g., valproate) can exacerbate metabolic imbalance.

Stressful events such as surgery or trauma may precipitate acute episodes.

Symptoms typically develop within the first few days to weeks of life after protein feeding begins.

Metabolic crises can occur rapidly, often within hours to days of an inciting event.

Late-onset presentations may have a more prolonged latency of months to years.

Newborn screening can detect biochemical abnormalities before symptom onset.

Delay between initial metabolic disturbance and clinical recognition can vary widely.

Early symptoms are nonspecific and mimic sepsis or other neonatal illnesses, leading to misdiagnosis.

Lack of awareness and limited access to newborn metabolic screening delays diagnosis.

Overlap with other organic acidemias complicates initial biochemical interpretation.

Normal initial ammonia or acid-base status may falsely reassure clinicians.

Rare late-onset forms present with subtle or intermittent symptoms, causing further delay.

Poor feeding and vomiting are early signs in neonates with propionic acidemia.

Lethargy and hypotonia indicate central nervous system involvement during metabolic decompensation.

Recurrent metabolic crises triggered by illness or fasting cause episodic deterioration.

Seizures may occur due to metabolic encephalopathy.

Developmental delay and intellectual disability are common long-term manifestations.

Neonates present with poor feeding, vomiting, lethargy, and hypotonia progressing to coma.

Rapid onset of metabolic acidosis, hyperammonemia, and encephalopathy following protein exposure.

Recurrent episodes of vomiting, dehydration, and altered mental status triggered by illness or fasting.

Developmental delay and movement disorders may appear after repeated metabolic crises.

Late-onset cases present with chronic vomiting, failure to thrive, and episodic neurologic symptoms.

Previous episodes of metabolic decompensation or unexplained neonatal illness.

History of feeding intolerance or failure to thrive in infancy.

Prior diagnosis of organic acidemia or metabolic disorder in the patient or siblings.

No significant past medical history in asymptomatic carriers or late-onset cases.

History of unexplained seizures or developmental delay may be present.

Siblings with similar early neonatal deaths or metabolic crises suggest autosomal recessive inheritance.

Consanguineous parents increase risk of affected offspring with biallelic PCCA or PCCB mutations.

Family history of organic acidemias or metabolic disorders may be present.

Carrier parents are typically asymptomatic but have a 25% recurrence risk for affected children.

Genetic counseling is important due to the heritable nature of the disorder.

Hypotonia and poor muscle tone are common in affected infants during acute metabolic crises.

Tachypnea due to metabolic acidosis is frequently observed in acute presentations.

Lethargy and decreased responsiveness may be evident during decompensation.

Hepatomegaly can be present due to metabolic stress and secondary liver involvement.

Failure to thrive and poor weight gain are common chronic findings.

Implement a low-protein diet to reduce intake of propiogenic amino acids such as isoleucine, valine, methionine, and threonine.

Provide emergency management with intravenous glucose and fluids during metabolic crises to prevent catabolism and promote anabolism.

Consider liver transplantation in severe cases to restore deficient propionyl-CoA carboxylase activity.